Saturday, July 11, 2026

Drug profile · INN

ly4395089

ly4395089 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — ly4395089
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

ly4395089 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN ly4395089

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. 95% condensed proanthocyanidins from grape seed extract Unknown · United Therapeutics Europe · Iron Deficiency Anemia

Frequently asked questions

What is ly4395089?

ly4395089 is an FDA-listed pharmaceutical active ingredient.